Centene Corp (CNC)vsGoldman Sachs Group Inc (GS)
CNC
Centene Corp
$62.33
-0.59%
HEALTHCARE · Cap: $32.19B
GS
Goldman Sachs Group Inc
$1,038.68
-0.23%
FINANCIAL SERVICES · Cap: $317.48B
Smart Verdict
WallStSmart Research — data-driven comparison
Centene Corp generates 190% more annual revenue ($178.33B vs $61.53B). GS leads profitability with a 29.4% profit margin vs -3.6%. CNC appears more attractively valued with a PEG of 1.25. GS earns a higher WallStSmart Score of 73/100 (B).
CNC
Buy57
out of 100
Grade: C
GS
Strong Buy73
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+85.0%
Fair Value
$268.78
Current Price
$62.33
$206.45 discount
Intrinsic value data unavailable for GS.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Generating 3.4B in free cash flow
Mega-cap, among the largest globally
Strong operational efficiency at 38.6%
Keeps 29 of every $100 in revenue as profit
Reasonable price relative to book value
Earnings expanding 24.2% YoY
Areas to Watch
ROE of -30.1% — below average capital efficiency
Currently unprofitable
Expensive relative to growth rate
Negative free cash flow — burning cash
Distress zone — elevated risk
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : CNC
The strongest argument for CNC centers on Price/Book, Free Cash Flow. PEG of 1.25 suggests the stock is reasonably priced for its growth.
Bull Case : GS
The strongest argument for GS centers on Market Cap, Operating Margin, Profit Margin. Profitability is solid with margins at 29.4% and operating margin at 38.6%. Revenue growth of 14.5% demonstrates continued momentum.
Bear Case : CNC
The primary concerns for CNC are Return on Equity, Profit Margin.
Bear Case : GS
The primary concerns for GS are PEG Ratio, Free Cash Flow, Altman Z-Score. Debt-to-equity of 6.10 is elevated, increasing financial risk.
Key Dynamics to Monitor
CNC profiles as a turnaround stock while GS is a mature play — different risk/reward profiles.
GS carries more volatility with a beta of 1.29 — expect wider price swings.
GS is growing revenue faster at 14.5% — sustainability is the question.
CNC generates stronger free cash flow (3.4B), providing more financial flexibility.
Bottom Line
GS scores higher overall (73/100 vs 57/100), backed by strong 29.4% margins and 14.5% revenue growth. CNC offers better value entry with a 85.0% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Centene Corp
HEALTHCARE · HEALTHCARE PLANS · USA
Centene Corporation is a large publicly traded company and a multi-line managed care enterprise that serves as a major intermediary for both government-sponsored and privately insured health care programs. It is a healthcare insurer that focuses on managed care for uninsured, underinsured, and low-income individuals.
Goldman Sachs Group Inc
FINANCIAL SERVICES · CAPITAL MARKETS · USA
The Goldman Sachs Group, Inc., is an American multinational investment bank and financial services company headquartered in New York City. It offers services in investment management, securities, asset management, prime brokerage, and securities underwriting. It also provides investment banking to institutional investors.
Compare with Other HEALTHCARE PLANS Stocks
Want to dig deeper into these stocks?